Do muscle enzyme changes forecast liver injury in polymyositis/dermatomyositis patients treated with methylprednisolone and methotrexate?

Annals of Clinical and Laboratory Science

Volumn 46, Issue 3, 2016, Pages 266-269

  Shi, Qiang ^a   Niu, Junwei ^b   Huang, Xusheng ^b   Pu, Chuanqiang ^b  

^a Hainan Branch of General Hospital of PLA   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Alanine aminotransferase; Creatine kinase; Dermatomyositis; Polymyositis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE MB; LACTATE DEHYDROGENASE; METHOTREXATE; METHYLPREDNISOLONE; MUSCLE ENZYME; CREATINE KINASE;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CREATINE KINASE BLOOD LEVEL; DERMATOMYOSITIS; FEMALE; FORECASTING; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER INJURY; MALE; POLYMYOSITIS; PRIORITY JOURNAL; ENZYMOLOGY; INJURIES; LIVER; METABOLISM; MUSCLE;

ADULT; ALANINE TRANSAMINASE; CREATINE KINASE; DERMATOMYOSITIS; FEMALE; HUMANS; LIVER; MALE; METHOTREXATE; METHYLPREDNISOLONE; MUSCLES;

EID: 84994144931     PISSN: 00917370     EISSN: 15508080     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med.1975; 292: 344-347.
2. Gazeley DJ, Cronin ME.Diagnosis and treatment of the idiopathic inflammatory myopathies. Ther Adv Musculoskelet Dis. 2011;3(6):315-24.
3. Dalakas MC, Hohlfeld R.Polymyositis and dermatomyositis. Lancet. 2003;362(9388):971-82.
4. HenricsonEK, AbreschRT, CnaanA, HuF, DuongT, ArrietaA etal.The cooperative international neuromuscular research group Duchenne natural history study: glucocorticoidtreatment preserves clinically meaningful functional milestones and reduces rate of disease progression asmeasured by manual muscle testing and other commonly used clinical trial outcome measures.Muscle Nerve. 2013;48(1):55-67.
5. RuhlCE, EverhartJE.Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United Statespopulation. Gastroenterology. 2009;136(2):477-85.
6. vanBoxtelAG, BramerS, SolimanHamadMA, vanStratenAH. Perioperative serum aspartate aminotransferase level as a predictor of survival after coronary artery bypassgrafting.Ann Thorac Surg. 2012;94(5):1492-8.
7. Gasper MC, Gilchrist JM.Creatine kinase: a review of its use in the diagnosis of muscle disease. Med Health R I. 2005;88(11):398,4004.
8. JoffeMM, LoveLA, LeffRL, FraserDD, TargoffIN, JE etal. Drugtherapy ofthe idiopathic inflammatory myopathies: predictorsofresponsetoprednisone, azathioprine,andmethotrexate and a comparison of their efficacy. Am J Med. 1993;94(4):379-87.
9. ErlacherP, LercherA, FalkensammerJ, NassonovEL, SamsonovMI, ShtutmanVZ, etal.Cardiac troponin and betatype myosin heavy chain concentrations in patients with polymyositis or dermatomyositis. Clin Chim Acta. 2001;306(1-2):27-33.
10. ZhangY, HuangJJ, WangZQ, WangN, WuZY.Value of muscle enzyme measurement in evaluating different neuromuscular diseases.Clin Chim Acta. 2012;413(3-4):520-4.
11. WongMH, SockalingamS, ZainA.Polymyositis associated with hepatitis B: management with entacavir and prednisolone. Int J Rheum Dis. 2011;14(3):e38-41.
12. RomagnuoloJ, SadowskiDC, LalorE, JewellL, ThomsonAB. Cholestatic hepatocellular injury with azathioprine:a case report and review ofthe mechanisms of hepatotoxicity. CanJGastroenterol. 1998t;12(7):479-83.
13. SchniderC,SeebachJD,RibiC,SpertiniF.Systemic and neurological uses of immunosuppressive agents.Rev Med Suisse. 2013;9(384):915-21.
14. Miyamoto K.Update of the treatment of multiple sclerosis. Nihon Rinsho. 2013;71(5):817-21.